Simultaneous determination of atenolol and chlorthalidone in pharmaceutical preparations by capillary-zone electrophoresis

Analytical Letters

Volumn 42, Issue 10, 2009, Pages 1458-1470

  Azzam, Khaldun Al ^a   Elbashir, Abdalla A ^a   Elbashir, Mohammed A ^a   Saad, Bahruddin ^a   Hamid, Shafida Abdul ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Atenolol; Capillary zone electrophoresis; Chlorthalidone; Pharmaceutical preparations

Indexed keywords

EID: 70349963000     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710902961065     Document Type: Article

References (25)

1. Abdel-Hamid, M. E. 2000. Comparative LC-MS and HPLC analyses of selected antiepileptics and beta-blocking drugs. Farmaco 55: 136-145.
2. Arias, R., R. M. Jimenez, R. M. Alonso, M. Telez, I. Arrieta, P. Flores, and E. Ortiz-Lastra. 2001. Determination of the b-blocker atenolol in plasma by capillary zone electrophoresis. J. Chromatogr. A 916: 297-304.
3. Balesteros, M. R., A. F. Faria, and A. L. Oliveira. 2007. Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis. J. Brazil. Chem. Soc. 18: 554-558.
4. Bonazzi, D., R. Gotti, V. Andrisano, and V. Cavrini. 1996. Derivative UV spectrophotometric determination of atenolol and metoprolol in single- and multi-component pharmaceutical dosage forms. Farmaco 51: 733-738.
5. Dadgar, D., and M. T. Kelly. 1988. Determination of chlorthalidone in human plasma by reversed-phase micellar liquid chromatography. Analyst 113: 1223-1227.
6. Degen, P. H., and A. Schweizer. 1977. Quantitative determination of drugs in biological materials by means of extractive alkylation and gas-liquid chromatography. J. Chromatogr. 142: 549-557.
7. El-Gindy, A., S. Emara, and A. Mostafa. 2005. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride, and chlorthalidone. Farmaco 60: 269-278.
8. El-Gindy, A., S. Sallam, and R. A. Abdel-salam. 2008. HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk. J. Sep. Sci. 31: 677-682.
9. Ferraro, M. C. F., P. M. Castellano, and T. S. Kaufman. 2003. Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms. Anal. Bioanal. Chem. 377: 1159-1164.
10. Ferraro, M. C. F., P. M. Castellano, and T. S. Kaufman. 2004. Chemometric determination of amiloride hydrochloride, atenolol, hydrochlorothiazide, and timolol maleate in synthetic mixtures and pharmaceutical formulations. J. Pharm. Biomed. Anal. 34: 305-314.
11. Giachetti, C., A. Tenconi, S. Canali, and G. Zanolo. 1997. Simultaneous determi-nation of atenolol and chlorthalidone in plasma by high-performance liquid chromatography application to pharmacokinetics studies in man. J. Chromatogr. B 698: 187-194.
12. International Conference Harmonization (ICH). 1995. Guideline for industry: Text on validation of analytical procedures, Q2A, Geneva, Switzerland.
13. Johnson, R. D., and R. J. Lewis. 2006. Quantitation of atenolol, metoprolol, and propranolol in postmortem human fluid and tissue specimens via LC=APCI-MS. Forensic Sci. Int. 156: 106-117.
14. Khuroo, A., S. Mishra, O. Singh, S. Saxena, and T. Monif. 2008. Simultaneous determination of atenolol and chlorthalidone by LC-MS-MS in human plasma. Chromatographia 68: 721-729.
15. Magnar, E., and G. Klas. 1974. Application of the extractive alkylation technique to the gas chromatographic determination of chlorthalidone in plasma in nanogram quantities. Anal. Chem. 46: 39-42.
16. Maguregui, M. I., R. M. Alonso, and R. M. Jimenez. 1997. Capillary zone electrophoretic method for the quantitative determination of the b-blocker atenolol in human urine. J. Liq. Chromatogr. Rel. Technol. 20: 3377-3387.
17. Maguregui, M. I., R. M. Alonso, and R. M. Jimenez. 1998. Simultaneous determination of the b-blocker atenolol and several complementary antihypertensive agents in pharmaceutical formulations and urine by capillary zone electrophoresis. J. Chromatogr. Sci. 36: 516-522.
18. Mohamed, A. E. L.-M. I., and H. Salem. 2005. Determination of antihypertensive mixtures by use of a chemometrics-assisted spectrophotometric method. Anal. Bioanal. Chem. 382: 1066-1072.
19. Moraes, C. F., E. R. Souza, V. C. Souza, E. F. F. Medeiros, T. F. Goncalves, J. O. Toledo, M. Karnikowski, L. Gomes, M. G. O. Karnikowski, C. Cordova, and O. T. Nobrega. 2008. A common polymorphism in the rennin angiotensin system is associated with differential outcome of antihypertensive pharma-cotherapy prescribed to Brazilian older women. Clin. Chim. Acta 396: 70-75.
20. Muirhead, D. C., and R. B. Christie. 1987. Simple, sensitive and selective high-performance liquid chromatographic method for analysis of chlorthalidone in whole blood. J. Chromatogr. 416: 420-425.
21. Rapado-Martinez, I., M. C. Garcia-Alvarez-Coque, and R. M. Villanueva-Camanas. 1997. Liquid chromatographic procedure for the evaluation of b-blockers in pharmaceuticals using hybrid mobile phases. J. Chromatogr. A 765: 221-231.
22. Salem, H. 2004. High-performance thin-layer chromatography for the determina-tion of certain antihypertensive mixtures. Sci. Pharm. 72: 157-174.
23. Sa'sa, S. I., I. M. Jalal, and H. S. Khalil. 1998. Determination of atenolol com-binations with hydrochlorothiazide and chlorthalidone in tablets formulations by reverse-phase HPLC. J. Liq. Chromatogr. 11: 1673-1696.
24. Vetuschi, C., and G. Ragno. 1990. Fourth UV derivative spectrophotometry for the simultaneous assay of atenolol and chlorthalidone in pharmaceuticals. Int. J. Pharm. 65: 177-181.
25. Wehner, W. 2000. Determination of atenolol/chlortalidone during dissolution of tablets with UV multicomponent analysis. Pharmazie 55: 543-544.